Livzon Pharmaceutical Group Co Ltd (000513):企業の財務・戦略的SWOT分析

◆英語タイトル:Livzon Pharmaceutical Group Co Ltd (000513) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH61206FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Livzon Pharmaceutical Group Co Ltd (Livzon) a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The company provides preparation drug products, bulk medicines and intermediates, and diagnostic reagents and equipment. Its products include menotropins injection, urofollitropin injection, perospirone hydrochloride tablets, and ranitidine bismuth citrate tablets, among others. Livzon offers diagnostic kits such as BV quick-test kit, anti-HCV rapid test, anti-HAV IgM ELISA kit, anti-TOXO IgG ELISA and HBsAg ELISA kit. The company offers drugs for various therapeutic areas such as antibiotics, antibacterial, gastrointestinal, psychotropic, antiviral, immunomodulation, anti-allergic and traditional Chinese medicine. It operates through its production facility located in Shanxi, Gansu and Yunan, China. Livzon is headquartered in Zhuhai, China.

Livzon Pharmaceutical Group Co Ltd Key Recent Developments

Mar 23,2021: Livzon Pharmaceutical announces of audited results for the year ended 31 December 2020
Jan 27,2021: Livzon Pharmaceutical Group : Announcement on progress of the reorganization
Mar 20,2020: Donated 22 million yuan to fight against the COVID-19 outbreak, Joincare and Livzon Group practiced social responsibility
Feb 13,2020: Livzon Pharmaceutical Group : Voluntary announcement progress of rerearch and development of products by a controlling subsidiary Livzon Diagnostics

This comprehensive SWOT profile of Livzon Pharmaceutical Group Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Livzon Pharmaceutical Group Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Livzon Pharmaceutical Group Co Ltd – Key Information
Livzon Pharmaceutical Group Co Ltd – Overview
Livzon Pharmaceutical Group Co Ltd – Key Employees
Livzon Pharmaceutical Group Co Ltd – Key Employee Biographies
Livzon Pharmaceutical Group Co Ltd – Key Operational Heads
Livzon Pharmaceutical Group Co Ltd – Major Products and Services
Livzon Pharmaceutical Group Co Ltd – History
Livzon Pharmaceutical Group Co Ltd – Company Statement
Livzon Pharmaceutical Group Co Ltd – Locations And Subsidiaries
Livzon Pharmaceutical Group Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Livzon Pharmaceutical Group Co Ltd – Business Description
Livzon Pharmaceutical Group Co Ltd – Corporate Strategy
Livzon Pharmaceutical Group Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Livzon Pharmaceutical Group Co Ltd – Strengths
Livzon Pharmaceutical Group Co Ltd – Weaknesses
Livzon Pharmaceutical Group Co Ltd – Opportunities
Livzon Pharmaceutical Group Co Ltd – Threats
Livzon Pharmaceutical Group Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Livzon Pharmaceutical Group Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Livzon Pharmaceutical Group Co Ltd, Key Information
Livzon Pharmaceutical Group Co Ltd, Key Ratios
Livzon Pharmaceutical Group Co Ltd, Share Data
Livzon Pharmaceutical Group Co Ltd, Major Products and Services
Livzon Pharmaceutical Group Co Ltd, History
Livzon Pharmaceutical Group Co Ltd, Key Employees
Livzon Pharmaceutical Group Co Ltd, Key Employee Biographies
Livzon Pharmaceutical Group Co Ltd, Key Operational Heads
Livzon Pharmaceutical Group Co Ltd, Other Locations
Livzon Pharmaceutical Group Co Ltd, Subsidiaries
Livzon Pharmaceutical Group Co Ltd, Key Competitors
Livzon Pharmaceutical Group Co Ltd, SWOT Analysis
Livzon Pharmaceutical Group Co Ltd, Ratios based on current share price
Livzon Pharmaceutical Group Co Ltd, Annual Ratios
Livzon Pharmaceutical Group Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Livzon Pharmaceutical Group Co Ltd (000513):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CBT Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CBT Pharmaceuticals Inc (CBT) is a pharmaceutical company that develops innovative medicines for cancer indications. The company's pipeline products include CBT-101, cMet inhibitor is being developed to target the epithelial to mesenchymal transition pathway. Its CBT-101 is developed for var …
  • Banco Bradesco SA:企業の戦略・SWOT・財務情報
    Banco Bradesco SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bradesco SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Cemat AS (CEMAT):企業の財務・戦略的SWOT分析
    Cemat AS (CEMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Essar Power Limited:電力:M&Aディール及び事業提携情報
    Summary Essar Power Limited (Essar Power) a subsidiary of Essar Energy Limited, is an electric utility. It produces electricity and thermal energy. The company generates power from naphtha, high-speed diesel, coal, natural gasoline liquid, and natural gas sources. Essar Power owns and operates co-ge …
  • Alpiq Holding AG:企業の戦略的SWOT分析
    Alpiq Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • BioMarin Pharmaceutical Inc (BMRN):製薬・医療:M&Aディール及び事業提携情報
    Summary BioMarin Pharmaceutical Inc (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals for treatment of serious diseases and medical conditions, such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasi …
  • Universal Robina Corp:企業の戦略・SWOT・財務情報
    Universal Robina Corp - Strategy, SWOT and Corporate Finance Report Summary Universal Robina Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Orica Ltd:企業の戦略・SWOT・財務分析
    Orica Ltd - Strategy, SWOT and Corporate Finance Report Summary Orica Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • SK Kaken Co Ltd (4628):企業の財務・戦略的SWOT分析
    SK Kaken Co Ltd (4628) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Husky Energy Inc (HSE)-石油・ガス分野:企業M&A・提携分析
    Summary Husky Energy Inc. (Husky) is an integrated oil and gas company. The company has operations in upstream and downstream sectors of oil and gas value chain. Its upstream operations include the exploration, development and production of crude oil, bitumen and natural gas. Husky also carried out …
  • Cencosud SA:企業のM&A・事業提携・投資動向
    Cencosud SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cencosud SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • CHS Inc (CHSCP):企業の財務・戦略的SWOT分析
    CHS Inc (CHSCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Hongkong Land Holdings Ltd:企業の戦略・SWOT・財務分析
    Hongkong Land Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Hongkong Land Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Enbridge Inc (ENB):企業の財務・戦略的SWOT分析
    Enbridge Inc (ENB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Hansen Medical Inc (HNSN)-医療機器分野:企業M&A・提携分析
    Summary Hansen Medical Inc (Hansen Medical), formerly Autocath Inc, a subsidiary of Auris Surgical Robotics Inc, is a medical device company that develops, manufactures and markets magellan robotic system for peripheral vascular intervention. The company’s products include robotic system, robotic ca …
  • Eesti Energia AS:電力:M&Aディール及び事業提携情報
    Summary Eesti Energia AS (Eesti Energia) is an international energy company. It offers energy solutions ranging from electricity, heat and fuel production to sales, customer service and ancillary energy services among others. Eesti Energia sells electricity to the Baltic retail customers and the who …
  • Magnis Energy Technologies Ltd (MNS):企業の財務・戦略的SWOT分析
    Magnis Energy Technologies Ltd (MNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SSP Group Limited (Foodservice):企業の戦略・SWOT・財務情報
    SSP Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary SSP Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • CellaVision AB (CEVI)-医療機器分野:企業M&A・提携分析
    Summary CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automate …
  • Wanhua Chemical Group Co Ltd (600309):企業の財務・戦略的SWOT分析
    Wanhua Chemical Group Co Ltd (600309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆